Case Report: Ofatumumab for the treatment of refractory anti-NMDAR-positive autoimmune encephalitis
This study reports three cases of refractory anti-NMDAR encephalitis patients who exhibited persistent severe neuropsychiatric symptoms after first-line immunotherapy (glucocorticoids, intravenous Immunoglobulin) and long-term (maintenance) immunothera…